Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus

Telix and Biokosmos Sign Distribution Agreement for Prostate Cancer Imaging in Greece and Cyprus

GlobeNewswire

January 27, 2022



MELBOURNE, Australia and ATHENS, Greece, Jan. 28, 2022 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive commercial distribution agreement with Athens-based BIOKOSMOS...

Related Keywords

Athens ,Attikír ,Greece ,Australia ,Japan ,United States ,Belgium ,Melbourne ,Victoria ,Canada ,Switzerland ,Cyprus ,Australian ,Cypriot ,Greek ,Kyahn Williamson ,Angelos Pagonis ,Richard Valeix ,Unitedstatesandmaynotbeofferedorsoldwithintheunited States ,Christian Behrenbruch ,European Association Of Urology ,Telix Pharmaceuticals ,Linkedin ,Drug Administration ,Australian Securities Exchange ,Australian Therapeutic Goods Administration ,Nuclear Medicine ,Corporate Communications ,Telix Pharmaceuticals Limited ,Biokosmos Sign Distribution Agreement ,Prostate Cancer Imaging ,Pharmaceuticals Limited ,Greek Territory ,Prostate Cancer ,Molecular Imaging ,Molecularly Targeted Radiation ,Managing Director ,Chief Executive ,Practice Guidelines ,